Harnessing the Brain's Tools for Killing Cancer Cells Could be a Key to Treating High-grade Gliomas.
Neurosurgery., Dec;71(6):N23-4 (2012)
Oxidative Stress is Associated With Cell Death, Wall Degradation, and Increased Risk of Rupture of the Intracranial Aneurysm Wall.
Neurosurgery., Oct (2012)
Recovery of cortical control over locomotion after spinal cord injury.
Neurosurgery., Oct;71(4):N19-20 (2012)
Novel triple-modality molecular imaging approach holds promise for improving brain tumor resection.
Neurosurgery., Aug;71(2):N14-5 (2012)
Biopsy neuropathology of cerebral ischemia associated with a developmental venous anomaly.
Clin Neurol Neurosurg., Jul (2012)
What sequences on high-field MR best depict temporal resolution of experimental ICH and edema formation in mice?
J. Biomed. Biotechnol., 2012:961461 (2012)
Neuroprosthetic learning utilizes the same neural circuitry required for motor learning.
Neurosurgery., Jun;70(6):N10 (2012)
A novel target for ischemic stroke therapy: pannexins.
Neurosurgery., Apr;70(4):N13-4 (2012)
Angiogram-negative subarachnoid hemorrhage: relationship between bleeding pattern and clinical outcome.
Neurocrit Care., Jun;16(3):389-98 (2012)
Intracellular signaling pathways and size, shape, and rupture history of human intracranial aneurysms.
Neurosurgery., Jun;70(6):1565-72; discussion 1572-3 (2012)
Neuronal transplants reconstitute complex neuronal circuitry and rescue phenotype.
Neurosurgery., Feb;70(2):N11-2 (2012)
Using non-coding small RNAs to develop therapies for Huntington's disease.
Gene Ther., Dec;18(12):1139-49 (2011)
Seizures and free radicals: the antioxidant may become the next anticonvulsant.
Neurosurgery., Dec;69(6):N12-3 (2011)
The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity.
J. Neurosci., Oct;31(41):14496-507 (2011)
Treatment of ruptured and unruptured cerebral aneurysms in the USA: a paradigm shift.
J Neurointerv Surg., May;4(3):182-9 (2012)
Carotid endarterectomy with primary closure: analysis of outcomes and review of the literature.
Neurosurgery., Mar;70(3):646-54; discussion 654-5 (2012)
The experience of pain and the putamen: a new link found with functional MRI and diffusion tensor imaging.
Neurosurgery., Oct;69(4):N12-3 (2011)
Memory training unlocks brain plasticity in prodromal Alzheimer's disease.
Neurosurgery., Aug;69(2):N13-4 (2011)
Î±-1 Adrenergic receptor signaling linked to memory dysfunction following brain trauma.
Neurosurgery., Apr;68(4):N16-8 (2011)
Battling brain diabetes: antioxidants may reduce cognitive deficits induced by cholesterol.
Neurosurgery., Jun;68(6):N15-7 (2011)
Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study.
J. Neurosurg., Oct;115(4):730-6 (2011)
Neuromodulation of the locus coeruleus: a key to controlling wakefulness.
Neurosurgery., Feb;68(2):N14-5 (2011)
Dipyrone inhibits neuronal cell death and diminishes hypoxic/ischemic brain injury.
Neurosurgery., Oct;69(4):942-56 (2011)
Use of a simple internal fiducial as an adjunct to enhance intraoperative ultrasound-assisted guidance: technical note.
Neurosurgery., Sep;69(1 Suppl Operative):ons34-9; discussion ons39 (2011)
Diffusion weighted imaging: what are we really seeing?
Neurosurgery., Dec;67(6):N26-9 (2010)
Electrical stimulation of the thalamus modulates cortico-cortical signaling.
Neurosurgery., Dec;67(6):N23-4 (2010)
Stenting versus endarterectomy for carotid-artery stenosis.
N. Engl. J. Med., Oct;363(18):1766; author reply 1768 (2010)
Novel neurogenesis drugs uncovered from in vivo chemical library screen.
Neurosurgery., Oct;67(4):N16-8 (2010)
Embolus extravasation: a new mechanism for microvascular recanalization?
Neurosurgery., Aug;67(2):N22-3 (2010)
Composite ganglioneuroma-paraganglioma of the filum terminale.
J Neurosurg Spine., Jun;12(6):709-13 (2010)
Noninvasive monitoring of neural activity with bioluminescence.
Neurosurgery., Jun;66(6):N16-7 (2010)
Regeneration of neuromuscular synapses: action of microRNA-206.
Neurosurgery., Apr;66(4):N19-20 (2010)
Complement in neuroprotection and neurodegeneration.
Trends Mol Med., Feb;16(2):69-76 (2010)
Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression.
Hum. Mol. Genet., Apr;19(8):1528-38 (2010)
Real-time multiphoton microscopy in moving animals: new frontier of functional imaging.
Neurosurgery., Feb;66(2):N12-3 (2010)
T-cell activation in ischemic stroke: a new therapeutic target for delayed infarct expansion?
Neurosurgery., Dec;65(6):N13 (2009)
Targeted oncogenes create a new realistic mouse model of glioblastoma multiforme.
Neurosurgery., May;64(5):N13 (2009)
Methazolamide and melatonin inhibit mitochondrial cytochrome C release and are neuroprotective in experimental models of ischemic injury.
Stroke., May;40(5):1877-85 (2009)
Allele-specific silencing of mutant Huntington's disease gene.
J. Neurochem., Jan;108(1):82-90 (2009)
Genomics of human glioblastoma multiforme: a glimpse of the future.
Neurosurgery., Dec;63(6):15 (2008)
Neuromotor prosthetics: brain-computer interfaces, a step closer to benefitting paralyzed patients.
Neurosurgery., Oct;63(4):N8-9 (2008)
Chiari I malformation as a cause of trigeminal neuralgia: case report.
Neurosurgery., Sep;63(3):E614-5; discussion E615 (2008)
Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease.
J. Neurosci., Sep;28(38):9473-85 (2008)
Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury.
Stroke., Feb;39(2):455-62 (2008)
Images in clinical medicine. Pneumocephalus associated with pneumosinus dilatans frontalis.
N. Engl. J. Med., Sep;357(11):1136 (2007)
Nortriptyline delays disease onset in models of chronic neurodegeneration.
Eur. J. Neurosci., Aug;26(3):633-41 (2007)
Clinical practice. Arteriovenous malformations of the brain.
N. Engl. J. Med., Jun;356(26):2704-12 (2007)
Increased stem cell proliferation in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.
J. Neurochem., Aug;102(4):1125-38 (2007)
Huntingtin inhibits caspase-3 activation.
EMBO J., Dec;25(24):5896-906 (2006)
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
J. Neuroimmunol., Jul;176(1-2):198-215 (2006)
Protective role of Cop in Rip2/caspase-1/caspase-4-mediated HeLa cell death.
Biochim. Biophys. Acta., Aug;1762(8):742-54 (2006)
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice.
Biochim. Biophys. Acta., Mar;1762(3):373-80 (2006)
Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease.
J. Neurosci., Dec;25(50):11645-54 (2005)
Increased generation of granule cells in adult Bcl-2-overexpressing mice: a role for cell death during continued hippocampal neurogenesis.
Eur. J. Neurosci., Oct;22(8):1907-15 (2005)
Intraoperative awakening for vision examination during ophthalmic artery aneurysm clipping: technical case report.
Neurosurgery., Apr;56(2 Suppl):E440; discussion E440 (2005)
Promethazine: a novel application as a neuroprotectant that reduces ischemia-mediated injury by inhibiting mitochondrial dysfunction.
Clin Neurosurg., 51:102-7 (2004)
The mitochondrial permeability transition as a target for neuroprotection.
J. Bioenerg. Biomembr., Aug;36(4):309-12 (2004)
Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology.
J. Exp. Med., Jul;200(2):211-22 (2004)
Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice.
J. Neurosci., Jun;24(26):5909-12 (2004)
Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury.
Proc. Natl. Acad. Sci. U.S.A., Mar;101(9):3071-6 (2004)
Minocycline is protective in a mouse model of Huntington's disease.
Ann. Neurol., Dec;54(6):841; author reply 842-3 (2003)
Fundamental role of the Rip2/caspase-1 pathway in hypoxia and ischemia-induced neuronal cell death.
Proc. Natl. Acad. Sci. U.S.A., Dec;100(26):16012-7 (2003)
Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease.
J. Neurochem., Dec;87(5):1184-92 (2003)
Apoptosis and caspases in neurodegenerative diseases.
N. Engl. J. Med., Apr;348(14):1365-75 (2003)
Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS.
Ann. Neurol., Feb;53(2):267-70 (2003)
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice.
Hum. Mol. Genet., Mar;11(6):633-40 (2002)
Caspases in Huntington's disease.
Neuroscientist., Dec;7(6):480-9 (2001)
Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction.
Neurosurgery., Jun;48(6):1393-9; discussion 1399-401 (2001)
Arteriovenous malformations: indications for stereotactic radiosurgery.
Clin Neurosurg., 47:242-8 (2000)
Prediction of aneurysm rupture site by an angiographically identified bleb at the aneurysm neck.
J. Neurosurg., Sep;93(3):517 (2000)
Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury.
Neuroscience., 99(2):333-42 (2000)
Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant.
J. Neurochem., Aug;75(2):847-52 (2000)
Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case report and review of the literature.
J. Neurosurg., Jan;92(1):165-9 (2000)
Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity.
Neuroreport., Feb;10(3):635-8 (1999)
Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic study.
Neurology., Jul;49(1):213-22 (1997)
Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein.
J. Cereb. Blood Flow Metab., Apr;17(4):370-5 (1997)
Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.
Proc. Natl. Acad. Sci. U.S.A., Mar;94(5):2007-12 (1997)
Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury.
J. Exp. Med., Mar;185(5):933-40 (1997)
Aneurysmal subarachnoid hemorrhage in a patient with bilateral A1 fenestrations associated with an azygos anterior cerebral artery. Case report and literature review.
J. Neurosurg., Apr;84(4):681-4 (1996)